Abstract
Many elderlies exhibited absent responses to influenza vaccines. Our exploration of this heterogeneity revealed associations with vaccine dose (HD vs. SD, OR: 0.59 (95%CrI, 0.4 to 0.87)), pre-vaccination titer levels (OR: 1.57 (95%CrI, 1.38 to 1.8), and gender (Male vs. Female OR: 2.12 (95%CrI, 1.38 to 3.25)).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yang Ge was supported by the Start-up Grant from the University of Southern Mississippi and NIH contract 75N93019C00052. Wangnan Cao was supported by Beijing Natural Science Foundation (L222029). Ted M. Ross is supported by the Georgia Research Alliance as an Eminent Scholar. Ye Shen received partial support from NIH grants/contracts R35GM146612, R01AI170116 and 75N93019C00052. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We conducted a secondary analysis on data collected from an ongoing human vaccine cohort study. The procedures, informed consent, and data collection documents of the cohort study were reviewed and approved by the Western Institutional Review Board and the Institutional Review Boards of the University of Pittsburgh and the University of Georgia.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Joint first authors
Conflicts of interest: None of the authors declare any conflicts of interest.
Funding sources: Yang Ge was supported by the Start-up Grant from the University of Southern Mississippi and NIH contract 75N93019C00052. Wangnan Cao was supported by Beijing Natural Science Foundation (L222029). Ted M. Ross is supported by the Georgia Research Alliance as an Eminent Scholar. Ye Shen received partial support from NIH grants/contracts R35GM146612, R01AI170116 and 75N93019C00052. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Ethics statement: We conducted a secondary analysis on data collected from an ongoing human vaccine cohort study. The procedures, informed consent, and data collection documents of the cohort study were reviewed and approved by the Western Institutional Review Board and the Institutional Review Boards of the University of Pittsburgh and the University of Georgia.
Data Availability Statement
The data supporting the findings of this study are available upon reasonable request.
